Galectin Therapeutics shareholders elect all 11 directors, approve say-on-pay, set frequency at 3 years

GALECTIN THERAPEUTICS INC

All 11 director nominees elected with >25M votes for each; highest was Benjamin S. Carson Sr. at 25.9M.
Advisory say-on-pay resolution approved: 25.3M for, 639k against, 310k abstain.
Shareholders chose a 3-year frequency for future say-on-pay votes (22.1M votes for 3 years).
Ratification of Cherry Bekaert LLP as independent auditor for FY2025 passed with 45.5M for, 142k against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.